Meridian Wealth Partners, LLC Dbv Technologies S.A. Transaction History

Meridian Wealth Partners, LLC

  • $640 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
BUY
$4.71 - $5.92 $9,420 - $11,840
2,000 New
2,000 $10,000
Q2 2021

Aug 12, 2021
SELL
$5.32 - $6.53 $10,640 - $13,060
-2,000 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$2.75 - $6.57 $5,500 - $13,140
2,000 New
2,000 $11,000

Others Institutions Holding DBVT

# of Institutions
2
Shares Held
3.2K
Call Options Held
0
Put Options Held
0
View Full List

About DBV Technologies S.A.

DBVT Quotes by TradingView
  • Ticker DBVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,776,992
  • Market Cap $599M
  • Description
  • DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...
More about DBVT
Track This Portfolio

Track Meridian Wealth Partners, LLC Portfolio

Follow Meridian Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meridian Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Meridian Wealth Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email